elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24679738-E3BFF702-AACF-44A8-9B07-6CE639EA2CB5
Q24679738-E3BFF702-AACF-44A8-9B07-6CE639EA2CB5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24679738-E3BFF702-AACF-44A8-9B07-6CE639EA2CB5
Multicentre phase II pharmacological evaluation of rhizoxin. Eortc early clinical studies (ECSG)/pharmacology and molecular mechanisms (PAMM) groups
P2860
Q24679738-E3BFF702-AACF-44A8-9B07-6CE639EA2CB5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24679738-E3BFF702-AACF-44A8-9B07-6CE639EA2CB5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6250e690f05cc40d888b4aac03c81edec97103ea
P2860
Phase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials Group.